HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Joseph W. Lewis, Jr. Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Magilligan, D. J. Articles by Ausman, J. I. Search for Related Content PubMed PubMed Citation Articles by Magilligan, D. J., Jr. Articles by Ausman, J. I.

Ann Thorac Surg 1986;42:360-364
© 1986 The Society of Thoracic Surgeons

---

Articles

Surgical Approach to Lung Cancer with Solitary Cerebral Metastasis: Twenty-Five Years' Experience

From the Division of Cardiac and Thoracic Surgery, Department of Neurological Surgery, Henry Ford Hospital, Detroit, Ml

^* Address reprint requests to Dr. Magilligan, 2799 W Grand Blvd, Detroit, MI 48202

From 1960 to 1985, 41 patients underwent resection of a lung cancer and one or more brain metastases. There were 24 men and 17 women ranging in age from 40 to 71 years (average, 56 years). Cell type was adenocarcinoma in 19 patients, squamous in 16, small cell in 4, and large cell in 2. Wedge resection was performed in 4 patients, lobectomy in 20, pneumonectomy in 14, and bilobectomy in 3. Brain irradiation was used for 25 patients (61%). To date, the longest survival is 18.3 years after craniotomy; mean survival is 2.3 years ± 3.8 (± standard deviation). Survival was 55 ± 7.9% (± standard error) at 1 year, 31 ± 7.4% at 2 years, 21 ± 6.5% at 5 years, and 15 ± 6.0% at 10 years.

Using multivariate analysis, we evaluated possible significant predictors of improved survival. Only wedge resection was a significant predictor (p < .01), which suggests better results with a small peripheral lung tumor. Results of our 25 years' experience using an aggressive approach to lung cancer with solitary cerebral metastasis indicate significantly improved patient survival that justifies its widespread use.

This article has been cited by other articles:

				D. S. Ettinger, W. Akerley, H. Borghaei, A. C. Chang, R. T. Cheney, L. R. Chirieac, T. A. D'Amico, T. L. Demmy, A. K. P. Ganti, R. Govindan, et al. Non-Small Cell Lung Cancer J Natl Compr Canc Netw, October 1, 2012; 10(10): 1236 - 1271. [Abstract] [Full Text] [PDF]

				D. S. Ettinger, W. Akerley, G. Bepler, M. G. Blum, A. Chang, R. T. Cheney, L. R. Chirieac, T. A. D'Amico, T. L. Demmy, A. K. P. Ganti, et al. Non-Small Cell Lung Cancer J Natl Compr Canc Netw, July 1, 2010; 8(7): 740 - 801. [Abstract] [Full Text] [PDF]

				K. F. Kwong, M. J. Edelman, M. Suntharalingam, L. B. Cooper, Z. Gamliel, W. Burrows, P. Hausner, L. A. Doyle, and M. J. Krasna High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1250 - 1257. [Abstract] [Full Text] [PDF]

				H. Vesselle, E. Turcotte, L. Wiens, R. Schmidt, J. E. Takasugi, T. Lalani, E. Vallieres, and D. E. Wood Relationship between Non-Small Cell Lung Cancer Fluorodeoxyglucose Uptake at Positron Emission Tomography and Surgical Stage with Relevance to Patient Prognosis Clin. Cancer Res., July 15, 2004; 10(14): 4709 - 4716. [Abstract] [Full Text] [PDF]

				V. Getman, E. Devyatko, D. Dunkler, F. Eckersberger, A. End, W. Klepetko, G. Marta, and M. R. Mueller Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment Eur J Cardiothorac Surg, June 1, 2004; 25(6): 1107 - 1113. [Abstract] [Full Text] [PDF]

				M. S. Kinch, M.-B. Moore, and D. H. Harpole Jr. Predictive Value of the EphA2 Receptor Tyrosine Kinase in Lung Cancer Recurrence and Survival Clin. Cancer Res., February 1, 2003; 9(2): 613 - 618. [Abstract] [Full Text] [PDF]

				P. S. Billing, D. L. Miller, M. S. Allen, C. Deschamps, V. F. Trastek, and P. C. Pairolero Surgical treatment of primary lung cancer with synchronous brain metastases J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 548 - 553. [Abstract] [Full Text] [PDF]

				P. Granone, S. Margaritora, A. D'Andrilli, A. Cesario, K. Kawamukai, and E. Meacci Non-small cell lung cancer with single brain metastasis: the role of surgical treatment Eur J Cardiothorac Surg, August 1, 2001; 20(2): 361 - 366. [Abstract] [Full Text] [PDF]

				K. Yokoi, N. Miyazawa, and T. Arai Brain Metastasis in Resected Lung Cancer: Value of Intensive Follow-up With Computed Tomography Ann. Thorac. Surg., February 1, 1996; 61(2): 546 - 550. [Abstract] [Full Text]

				D. E. Van Raemdonck, A. Schneider, and R. J. Ginsberg Surgical treatment for higher stage non-small cell lung cancer Ann. Thorac. Surg., November 1, 1992; 54(5): 999 - 1013. [Abstract] [PDF]

				J. D. Miller, L. A. Gorenstein, and G. A. Patterson Staging: The key to rational management of lung cancer Ann. Thorac. Surg., January 1, 1992; 53(1): 170 - 178. [Abstract] [PDF]

				J. B. D. Mark How Far Should We Go? Ann. Thorac. Surg., July 1, 1988; 46(1): 3 - 3. [PDF]

				J. R. Hankins, J. E. Miller, M. Salcman, F. Ferraro, D. C. Green, S. Attar, and J. S. McLaughlin Surgical Management of Lung Cancer with Solitary Cerebral Metastasis Ann. Thorac. Surg., July 1, 1988; 46(1): 24 - 28. [Abstract] [PDF]